Short-Term Efficacy and Safety of Adding Ezetimibe to Current Regimen of Lipid-Lowering Drugs in Human Immunodeficiency Virus-Infected Thai Patients Treated with Protease Inhibitors. [electronic resource]
Producer: 20181002Description: 220-224 p. digitalISSN:- 1884-2836
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.